Improving Genetic Counseling for BRCA+ Mothers
Recruiting now · Not applicable
Conditions studied: Breast Cancer
In brief
Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly your blood relatives, are at increased risk for the disease across the lifespan. This includes biological children, both male and female. We do not yet know the best ways to educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share genetic information with their children or manage their thoughts and feelings. The purpose of this study is to help mothers make more informed choices about talking with children about hereditary breast cancer, provide them with age-and gender-appropriate information and emotional support, and improve their psychological well-being.
Key facts
- Study ID
- NCT04258280
- Run by
- Georgetown University
- People needed
- 200
- Starts
- 2020-07-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2024-09-27
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Mothers/primary caregivers to adolescents/young adults ages 13-24 years-old.
- Participating in genetic testing for hereditary breast cancer.
- Adequately speak/read English.
You may not qualify if…
- Does not meet inclusion criteria.
Where it is running
- MedStar Georgetown University Hospital — Washington D.C., District of Columbia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.